Executive Director, Clinical Strategy
United States of America
Dr. Chulay earned a medical degree from Northwestern University Medical School and a degree in tropical medicine and hygiene from the London School of Hygiene and Tropical Medicine. He served his residency at Cleveland Metropolitan General Hospital and was a fellow in Infectious Disease at WRAIR. He has been a member of the Institute of Medicine Committee on Prevention and Control of Malariaand an advisor to the Institute of Medicine Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee (RAC). He has published more than 100 papers in peer-reviewed journals and is a reviewer for several leading medical journals.
He has achieved Investigational New Drug submissions for programs in Alpha-1 Antitrypsin Deficiency, Leber Congenital Amaurosis, X-linked Retinoschisis and Achromatopsia, and published clinical trial results for the first two of these programs.